Eli Lilly to sign $2bn deal for AI drug development with Hong Kong biotech - Financial Times

Corroborated by 5 sources from 5 publishers

ushealth1d ago

TL;DR

Reports differ across sources; according to cnbc.com, watch now Hong Kong's Insilico reaches $2.75 billion Eli Lilly deal for AI-developed drugs Hong-Kong listed Insilico Medicine has announced a new $2.75 billion deal with U.S.

Sources